Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for cannabis dependence
ACTRN12616000103460Phase 3Completed
- Sponsor
- The University of Sydney
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cannabis use disorder (CUD) comparing Sativex with Placebo spray (2 arms). Primary endpoints: Unsanctioned cannabis use, Treatment retention and 1 more. Started Feb 2016; status: completed.
02
Drugs
cannabidiol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on ACTRN12616000103460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000103460.